News

uMotif signs new partnership with AstraZeneca to enhance patient data capture

uMotif has signed a partnership agreement with AstraZeneca, a top-10 global pharmaceutical company
Read more

uMotif and QuintilesIMS in partnership with the NHS Cancer Vanguard and Merck launch a unique investigation into the experience of Colorectal Cancer Patients

uMotif in partnership with QuintilesIMS was chosen from dozens of responses to the ‘Pharma Challenge’, an invitation issued by the NHS Cancer Vanguard to the pharmaceutical and life sciences industry to help the NHS make better use of medicines and minimise waste.
Read more

Simple health app allowing patients with long term conditions to record their symptoms could save NHS £1bn a year

A new study in Parkinson’s proves the value and clinical impact of patients using their own devices to capture and monitor symptoms and treatments.
Read more

Capturing trial data to help understand the good days, as well as the bad: Sam's Story

Using the uMotif app during the Smart PD trial, Sam was able to get a better understanding of her Parkinson's
Read more

uMotif announce partnership with Global Kinetics

​Global Kinetics Corporation and uMotif have announced a new partnership to offer a comprehensive, validated and simple to use data capture platform to advance the treatment and understanding of Parkinson's disease.
Read more

Putting patients at the centre of research - Mick's experience of using uMotif

Watch the latest video, where one of the participants from our observational study describes his experience using the uMotif app
Read more

Cloudy with a Chance of Pain is Front Page News!

Our collaboration with the University of Manchester is featured on the FRONT PAGE of the Daily Express today - describing the preliminary findings that the weather may.....
Read more

100 For Parkinson’s enters its last two weeks of recruitment

Our ground-breaking study in partnership with The Cure Parkinson’s Trust, Parkinson’s UK and the European Parkinson’s Disease Association is entering the last two weeks of recruitment. There’s still time for people with Parkinson’s and healthy volunteers to join over 4000 others and track their health for 100 days using their own smartphone or tablet.
Read more

Digital Innovators Power List

umotif has been named as one of the South East's most visionary digital companies in the inaugural 'Digital Innovators Power List' launched today by international law firm Bird & Bird LLP and London-based news brand, City A.M.
Read more

uMotif and Oxford University Innovation collaborate on world’s largest health tracking study to improve the lives of those with Parkinson’s

 One person in every 500 has Parkinson’s disease, with more than 127,000 people in the UK and around 10 million people globally diagnosed with the condition.  A unique global health project – 100 for Parkinson’s - has engaged thousands of people across the world to track their health, using smartphone technology, to provide valuable new insights on the impact of Parkinson’s on their daily lives.   With over 4,000 participants and millions of data points captured, the study is now the world’s largest of its type in Parkinson’s, capturing more high quality health data from more patients over a longer period of time.
Read more

It's World Parkinson's Congress and we've more data to share...

World Parkinson's Congress is ending today in Portland, so we've published some more data from 100 For Parkinson's on Mood, Sleep and Stress levels of those with and without Parkinson's...
Read more

Cloudy with a Chance of Pain study

​Preliminary results, national media coverage and another 2,500 participants: It's been another couple of eventful weeks for the ground-breaking Cloudy with a Chance of Pain study
Read more

Partnership with Picker Institute, using patient experience to reduce readmissions

We're delighted to be working in partnership with the Picker Institute – the leading charity improving healthcare through measurement of experience.
Read more

Data from global 100 for Parkinson’s study

​We launched our global 100 for Parkinson's study at the start of 2016, and have had an incredible response.
Read more

Guardian article: People powered health

u​Motif CEO Bruce Hellman wrote an article in the Guardian on the future of technology in healthcare.
Read more

IDEO Startup In Residence

A year ago the uMotif team started working with the IDEO London team, as part of their incredible Startup In Residence Programme.
Read more